SherazMarkar United Kingdom

• ROBOTIC ESOPHAGECTOMY–TRANS-THORACIC WITH VARIOUS ANASTOMOSES
  115-1
  MarkVan Berge Henegouwen Speaker Netherlands
• MINIMALLY-INVASIVE MCKEOWN ESOPHAGECTOMY
  115-2
  HirotoshiKikuchi Speaker Japan
• OPEN LEFT THORACO-ABDOMINAL ESOPHAGOGASTRECTOMY: INDICATIONS AND SEVERAL ALTERNATE CONDUITS AND WHEN TO USE THEM (E.G. PEDICLED JEJUNAL INTERPOSITION, GASTRIC CONDUIT, COLON)
  115-3
  Lorenzo E.Ferri Speaker Canada
• MINIMALLY INVASIVE SUBTOTAL GASTROECTOMY WITH D2 LYPHADENECTOMY DEMONSTRATING SEVERAL ANASTOMOTIC TECHNIQUES
  115-4
  MasashiYoshida Speaker Japan
• RE-OPERATIVE SURGERY AFTER THE FAILED FUNDOPLICATION
  115-5
  ItaloBraghetto Speaker Chile
• LAPAROSCOPIC REPAIR OF PARAESOPHAGEAL HERNIA
  115-6
  John G.Hunter Speaker United States

• INTRODUCCIÓN Y PRESENTATCIÓN
  AMCE
  1116-1
  AlejandroAlfaro G Speaker Mexico
• ESTADO ACTUAL DEL ABORDAJE MÍNIMAMENTE INVASIVO PARA EL CÁNCER GÁSTRICO
  AMCE
  1116-2
  EnriqueLanzarini Speaker Chile
• ES NECESARIO REALIZAR OMENTECTOMÍA TOTAL EN LA CIRUGÍA PARA CÁNCER GÁSTRICO LOCALMENTE AVANZADO? RESULTADOS DEL ESTUDIO OMEGA
  AMCE
  1116-3
  Suzanne S.Gisbertz Speaker Netherlands
• DE LA ESOFAGECTOMÍA ABIERTA A LA ROBÓTICA - BENEFICIOS Y LIMITACIONES
  AMCE
  1116-4
  Alberto MitsuoLeon Takahashi Speaker Mexico
• OPTIMIZACIÓN DE LA ATENCIÓN PERIOPERATORIA DEL PACIENTE CON ESOFACECTOMÍA MEDIANTE PROGRAMAS MULITMODALES DE RECUPERACIÓN MEJORADA
  AMCE
  1116-5
  Lorenzo E.Ferri Speaker Canada
• CÓMO DEFINIMOS CALIDAD QUIRÚGICA PARA CIRUGÍA DEL CÁNCER ESOFAGOGÁSTRICO
  AMCE
  1116-6
  SherazMarkar Conferencia Magistral United Kingdom
• PREGUNTAS Y RESPUESTAS
  AMCE
  1116-7
  Alberto MitsuoLeon Takahashi Speaker Mexico

• UPPER GI - ESOPHAGEAL CANCER WITH CLINICAL COMPLETE RESPONSE POST CHEMORADIATION - EARLY ELECTIVE SURGERY
  216-1
  SherazMarkar Speaker United Kingdom
• UPPER GI - ESOPHAGEAL CANCER WITH CLINICAL COMPLETE RESPONSE POST CHEMORADIATION - SURVEILLANCE AND DELAYED SURGERY
  216-2
  Simon Ying-KitLaw Speaker Hong Kong, China
• HPB – NEOADJUVANT CHEMOTHERAPY FOR RESECTABLE PANCREAS CANCER - SURGERY + ADJUVANT THERAPY
  216-3
  DanielFigueroa Tentori Speaker Mexico
• HPB – NEOADJUVANT CHEMOTHERAPY FOR RESECTABLE PANCREAS CANCER - NEOADJUVANT THERAPY
  216-4
  TaylorRiall Speaker United States
• CRC – NEOADJUVANT TREATMENT FOR PMMR ADVANCED COLON CANCER? CONS
  216-5
  AlessandroFichera Speaker United States
• CRC – NEOADJUVANT TREATMENT FOR PMMR ADVANCED COLON CANCER? PROS
  216-6
  JamieMurphy Speaker United Kingdom

• CURRENT PARADIGM IN MANAGEMENT OF LOCALLY ADVANCED ESOPHAGEAL CANCER
  313-1
  Lorenzo E.Ferri Speaker Canada
• T4B ESOPHAGEAL SQUAMOUS CELL CARCINOMA: PRACTICAL APPROACH TO MANAGEMENT OF BORDERLINE RESECTABLE CANCERS
  313-2
  HirotoshiKikuchi Speaker Japan
• MODERN MANAGEMENT OF GASTRO-ESOPHAGEAL JUNCTIONAL CANCERS: MULTIMODAL THERAPY AND SURGICAL APPROACH
  313-3
  Suzanne S.Gisbertz Speaker Netherlands
• LIMITED METASTASES FROM GASTRO ESOPHAGEAL CANCER: A SURGICAL DISEASE?
  313-4
  SherazMarkar Speaker United Kingdom
• OPTIMIZING PERI-OPERATIVE OUTCOMES FOR THE ESOPHAGEAL CANCER PATIENT
  313-5
  WayneHofstetter Speaker United States

• NOVEL ROBOTIC PLATFORMS
  316-1
  James OhPark Speaker United States
• AI IN SURGERY
  316-2
  JesusTapia Speaker Mexico
• AI AND EXTENDED REALITY: TRANSFORMING SURGICAL EDUCATION
  316-3
  GeraldFried Speaker Canada
• METAVERSE IN SURGERY
  316-4
  MicheleAmmendola Speaker Italy
• MAGNETIC SURGERY
  316-5
  MichelGagner Speaker Canada
• FLUORESCENCE GUIDED UPPER GI SURGERY LYMPHADENECTOMY
  316-6
  Suzanne S.Gisbertz Speaker Netherlands